Targeting Non-virally Suppressed Adults With Alcohol Use Disorder in HIV Primary Care
Stopped early · Not applicable
Conditions studied: Alcohol Dependence, HIV/AIDS
In brief
The proposed pilot study is a randomized feasibility trial of technology-enhanced brief intervention for drinking reduction and antiretroviral therapy (ART) adherence in 60 non-virally suppressed HIV participants who meet criteria for DSM-5 Alcohol Use Disorder (AUD) in a Primary Care clinic. Study sample will be recruited from a large urban HIV primary care clinic at Montefiore Hospital where the investigators previously successfully enrolled, randomized and treated study participants The interventions consist of brief meetings to discuss drinking and ART adherence enhanced with daily self-monitoring through the use of a smartphone application that tracks drinking and other aspects of health. These meetings will be based on the Clinician's Guide, a brief intervention for heavy drinking in primary care settings advocated by the National Institute on Alcohol Abuse and Alcoholism. Participants will be assessed at baseline, 30, 60, 90 days, and 6 months after baseline. By the end of treatment (60 days) and throughout the follow-up period, alcohol use is expected to highest among participants who receive the Clinician's Guide alone, and lowest among participants who receive the Clinician's Guide plus the smartphone application.
Key facts
- Study ID
- NCT04280068
- Run by
- Research Foundation for Mental Hygiene, Inc.
- People needed
- 3
- Starts
- 2020-03-02
- Expected to finish
- 2020-06-30
- Last updated by the study team
- 2020-10-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 18 and older
- Patient had 4 or more drinks on any day in prior 30 days
- Patient meets criteria for DSM5 current alcohol dependence
- HIV+
- Non-virally suppressed (HIV RNA > 200 last check)
- Able to give informed consent
You may not qualify if…
- Multi-drug resistant HIV and no fully suppressive treatment regimen is available
- Unwilling to take ART medications
- Patient is psychotic, suicidal, or homicidal
- Patient has gross cognitive impairment
- Patient does not speak English or Spanish
- Patient has definite plans to leave the greater New York metropolitan area within the study period
- Patient has vision/hearing impairment that would preclude participation
Where it is running
- Montefiore Hospital Infectious Disease clinic — The Bronx, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.